SLI
2.034,98
PKT
-43,10
PKT
-2,07
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.10.10 | Novartis buy | SEB AG | |
| 21.10.10 | UBS buy | Vontobel Research | |
| 21.10.10 | Novartis buy | Vontobel Research | |
| 20.10.10 | Kühne + Nagel International hold | Société Générale Group S.A. (SG) | |
| 20.10.10 | Kühne + Nagel International buy | ING | |
| 19.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 20.10.10 | UBS hold | UniCredit Research | |
| 20.10.10 | UBS buy | UniCredit Research | |
| 21.10.10 | Novartis buy | Banc of America Securities-Merrill Lynch | |
| 18.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 15.10.10 | Novartis buy | Société Générale Group S.A. (SG) | |
| 15.10.10 | Straumann hold | Vontobel Research | |
| 14.10.10 | Kühne + Nagel International hold | Société Générale Group S.A. (SG) | |
| 14.10.10 | Sonova halten | Vontobel Research | |
| 13.10.10 | Novartis buy | Vontobel Research | |
| 13.10.10 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 12.10.10 | Novartis buy | Vontobel Research | |
| 13.10.10 | Novartis buy | Citigroup Corp. | |
| 12.10.10 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 12.10.10 | Nestlé buy | ING | |
| 11.10.10 | Givaudan hold | UniCredit Research | |
| 08.10.10 | Straumann hold | Vontobel Research | |
| 08.10.10 | Givaudan hold | Vontobel Research | |
| 11.10.10 | Novartis buy | SEB AG | |
| 07.10.10 | Zurich Insurance halten | Independent Research GmbH | |
| 07.10.10 | Logitech buy | Vontobel Research | |
| 07.10.10 | Novartis buy | Vontobel Research | |
| 07.10.10 | Zurich Insurance buy | Vontobel Research | |
| 07.10.10 | Novartis buy | UBS AG | |
| 05.10.10 | UBS buy | Vontobel Research | |
| 05.10.10 | Novartis buy | Vontobel Research | |
| 06.10.10 | UBS kaufen | Independent Research GmbH | |
| 04.10.10 | Novartis neutral | UBS AG | |
| 01.10.10 | UBS kaufen | Independent Research GmbH | |
| 01.10.10 | Givaudan hold | Vontobel Research | |
| 01.10.10 | UBS buy | Vontobel Research | |
| 01.10.10 | Holcim overweight | HSBC | |
| 01.10.10 | Novartis buy | Vontobel Research | |
| 01.10.10 | Kühne + Nagel International buy | Vontobel Research | |
| 01.10.10 | Nestlé halten | Der Aktionärsbrief |